Cipla Ltd
Ipratropium (40mcg)
Ipravent Rotacaps is an anticholinergic medicine used to treat chronic obstructive pulmonary disease and asthma by relaxing the muscles of the airways and easing symptoms such as chest tightness, shortness of breath, wheezing, and coughing.
Capsule
Ipravent Rotacaps is only for inhalational use and should be taken in the dose and duration as prescribed by your doctor. The dose and frequency of use depend on the condition being treated. It does not prevent already started breathing trouble or asthma attacks, so always carry your medical inhaler with you for emergencies. Common side effects include headache, dizziness, throat irritation, cough, dry mouth, and nausea.
Take this medicine in the dose and duration as advised by your doctor.
Ipravent Rotacaps is an anticholinergic medication that works by relaxing the muscles in the airways and widens the airways, making breathing easier.
Ipravent Rotacaps makes breathing easier for patients with COPD and asthma It does not work right away and should not be used to relieve sudden breathing problems Use your rescue inhaler to control sudden difficulty in breathing Dry mouth may occur as a side effect, and frequent mouth rinses, good oral hygiene, increased water intake, and sugarless candy may help Gargle with warm water after each inhalation to avoid any fungal infections in your mouth and throat
No, Ipravent Rotacaps is not a steroid-based medication.
No, Ipravent Rotacaps is not a narcotic and does not contain any controlled substances.
Ipravent Rotacaps does not contain opium or any of its derivatives.
No, there is no known association between Ipravent Rotacaps and weight gain as a side effect.
Yes, constipation is a reported side effect of Ipravent Rotacaps in some patients.
Ipravent Rotacaps may lead to tachycardia as a potential side effect in certain patients, although it is not a common occurrence.
There is no established association between Ipravent Rotacaps and changes in blood pressure.
Ipratropium bromide and albuterol are distinct medications, although they both serve as bronchodilators to relax air passages and facilitate easier breathing.
Budesonide and ipratropium/ipratropium bromide belong to different medication classes but are used in the treatment of bronchitis, asthma, and related conditions either alone or in combination.
Yes, Ipravent Rotacaps is classified as a bronchodilator for the treatment of bronchitis, asthma, and associated conditions.
Ipravent Rotacaps functions as a short-acting bronchodilator.
Yes, Ipravent Rotacaps is an anticholinergic bronchodilator.
Ipravent Rotacaps can be safely used in infants, and patients should adhere to the doctor's advice regarding its use.
No, Ipravent Rotacaps is intended for maintenance treatment of bronchospasm rather than the initial treatment or rescue therapy during acute episodes.
Yes, Ipravent Rotacaps can be employed as monotherapy in the management of bronchospasm, asthma, and associated conditions.
Yes, all formulations of Ipravent Rotacaps contain an expiry date. Patients should verify the correct expiration date on the packaging.